Aradigm Corporation

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and smoking cessation.
Type
Public
HQ
Hayward, US
Founded
1991
Employees
16 (est)

Aradigm Corporation Locations

Hayward, US

Aradigm Corporation Metrics

Aradigm Corporation Summary

Founding Date

1991

Market capitalization

$32.1 M

Closing share price

$2.29

Aradigm Corporation Market Value History

Aradigm Corporation Company Life

You may also be interested in